Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen
This study has been completed.
Sponsor:
Ludwig Institute for Cancer Research
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
Ludwig Institute for Cancer Research
ClinicalTrials.gov Identifier:
NCT00293215
First received: February 15, 2006
Last updated: May 11, 2007
Last verified: May 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2007 |
| Estimated Primary Completion Date: | No date given |